<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<style>body{background-color:white;}</style>


</head>
<body>
<div id="jjqksrldvd" style="padding-left:0px;padding-right:0px;padding-top:10px;padding-bottom:10px;overflow-x:auto;overflow-y:auto;width:auto;height:auto;">
  <style>#jjqksrldvd table {
  font-family: sans, system-ui, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
}

#jjqksrldvd thead, #jjqksrldvd tbody, #jjqksrldvd tfoot, #jjqksrldvd tr, #jjqksrldvd td, #jjqksrldvd th {
  border-style: none;
}

#jjqksrldvd p {
  margin: 0;
  padding: 0;
}

#jjqksrldvd .gt_table {
  display: table;
  border-collapse: collapse;
  line-height: normal;
  margin-left: auto;
  margin-right: auto;
  color: #333333;
  font-size: small;
  font-weight: normal;
  font-style: normal;
  background-color: #FFFFFF;
  width: auto;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #A8A8A8;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #A8A8A8;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
}

#jjqksrldvd .gt_caption {
  padding-top: 4px;
  padding-bottom: 4px;
}

#jjqksrldvd .gt_title {
  color: #333333;
  font-size: 125%;
  font-weight: initial;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-color: #FFFFFF;
  border-bottom-width: 0;
}

#jjqksrldvd .gt_subtitle {
  color: #333333;
  font-size: 85%;
  font-weight: initial;
  padding-top: 3px;
  padding-bottom: 5px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-color: #FFFFFF;
  border-top-width: 0;
}

#jjqksrldvd .gt_heading {
  background-color: #FFFFFF;
  text-align: center;
  border-bottom-color: #FFFFFF;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#jjqksrldvd .gt_bottom_border {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#jjqksrldvd .gt_col_headings {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#jjqksrldvd .gt_col_heading {
  color: #FFFFFF;
  background-color: #086EA1;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 6px;
  padding-left: 5px;
  padding-right: 5px;
  overflow-x: hidden;
}

#jjqksrldvd .gt_column_spanner_outer {
  color: #FFFFFF;
  background-color: #086EA1;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  padding-top: 0;
  padding-bottom: 0;
  padding-left: 4px;
  padding-right: 4px;
}

#jjqksrldvd .gt_column_spanner_outer:first-child {
  padding-left: 0;
}

#jjqksrldvd .gt_column_spanner_outer:last-child {
  padding-right: 0;
}

#jjqksrldvd .gt_column_spanner {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 5px;
  overflow-x: hidden;
  display: inline-block;
  width: 100%;
}

#jjqksrldvd .gt_spanner_row {
  border-bottom-style: hidden;
}

#jjqksrldvd .gt_group_heading {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  color: #333333;
  background-color: #E9F2F8;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  text-align: left;
}

#jjqksrldvd .gt_empty_group_heading {
  padding: 0.5px;
  color: #333333;
  background-color: #E9F2F8;
  font-size: 100%;
  font-weight: initial;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: middle;
}

#jjqksrldvd .gt_from_md > :first-child {
  margin-top: 0;
}

#jjqksrldvd .gt_from_md > :last-child {
  margin-bottom: 0;
}

#jjqksrldvd .gt_row {
  padding-top: 3px;
  padding-bottom: 3px;
  padding-left: 5px;
  padding-right: 5px;
  margin: 10px;
  border-top-style: solid;
  border-top-width: 1px;
  border-top-color: #CCCCCC;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  overflow-x: hidden;
}

#jjqksrldvd .gt_stub {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
}

#jjqksrldvd .gt_stub_row_group {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
  vertical-align: top;
}

#jjqksrldvd .gt_row_group_first td {
  border-top-width: 2px;
}

#jjqksrldvd .gt_row_group_first th {
  border-top-width: 2px;
}

#jjqksrldvd .gt_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 3px;
  padding-bottom: 3px;
  padding-left: 5px;
  padding-right: 5px;
}

#jjqksrldvd .gt_first_summary_row {
  border-top-style: solid;
  border-top-color: #D3D3D3;
}

#jjqksrldvd .gt_first_summary_row.thick {
  border-top-width: 2px;
}

#jjqksrldvd .gt_last_summary_row {
  padding-top: 3px;
  padding-bottom: 3px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#jjqksrldvd .gt_grand_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#jjqksrldvd .gt_first_grand_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-style: double;
  border-top-width: 6px;
  border-top-color: #D3D3D3;
}

#jjqksrldvd .gt_last_grand_summary_row_top {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-style: double;
  border-bottom-width: 6px;
  border-bottom-color: #D3D3D3;
}

#jjqksrldvd .gt_striped {
  background-color: #F2F2F2;
}

#jjqksrldvd .gt_table_body {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#jjqksrldvd .gt_footnotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#jjqksrldvd .gt_footnote {
  margin: 0px;
  font-size: 90%;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#jjqksrldvd .gt_sourcenotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#jjqksrldvd .gt_sourcenote {
  font-size: 90%;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#jjqksrldvd .gt_left {
  text-align: left;
}

#jjqksrldvd .gt_center {
  text-align: center;
}

#jjqksrldvd .gt_right {
  text-align: right;
  font-variant-numeric: tabular-nums;
}

#jjqksrldvd .gt_font_normal {
  font-weight: normal;
}

#jjqksrldvd .gt_font_bold {
  font-weight: bold;
}

#jjqksrldvd .gt_font_italic {
  font-style: italic;
}

#jjqksrldvd .gt_super {
  font-size: 65%;
}

#jjqksrldvd .gt_footnote_marks {
  font-size: 75%;
  vertical-align: 0.4em;
  position: initial;
}

#jjqksrldvd .gt_asterisk {
  font-size: 100%;
  vertical-align: 0;
}

#jjqksrldvd .gt_indent_1 {
  text-indent: 5px;
}

#jjqksrldvd .gt_indent_2 {
  text-indent: 10px;
}

#jjqksrldvd .gt_indent_3 {
  text-indent: 15px;
}

#jjqksrldvd .gt_indent_4 {
  text-indent: 20px;
}

#jjqksrldvd .gt_indent_5 {
  text-indent: 25px;
}

#jjqksrldvd .katex-display {
  display: inline-flex !important;
  margin-bottom: 0.75em !important;
}

#jjqksrldvd div.Reactable > div.rt-table > div.rt-thead > div.rt-tr.rt-tr-group-header > div.rt-th-group:after {
  height: 0px !important;
}
</style>
  <table class="gt_table" data-quarto-disable-processing="false" data-quarto-bootstrap="false">
  <thead>
    <tr class="gt_col_headings">
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" style="font-size: small; font-weight: bold; border-bottom-width: 1px; border-bottom-style: solid; border-bottom-color: grey70;" scope="col" id="label">label</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" style="font-size: small; font-weight: bold; border-bottom-width: 1px; border-bottom-style: solid; border-bottom-color: grey70;" scope="col" id="Answers">Answers</th>
    </tr>
  </thead>
  <tbody class="gt_table_body">
    <tr><td headers="label" class="gt_row gt_left"><div data-qmd-base64="SXMgdGhlcmUgYW55IG90aGVyIGludGVydmVudGlvbi9zdXBwb3J0IHN0cmF0ZWd5IHRoYXQgeW91IGZlZWwgaXMgdmVyeSBpbXBvcnRhbnQ/"><div class='gt_from_md'><p>Is there any other intervention/support strategy that you feel is very important?</p>
</div></div></td>
<td headers="value" class="gt_row gt_left"><div data-qmd-base64="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"><div class='gt_from_md'><p>Sepsis preventive strategies (IPC)<br> Monitoring of adequacy of oxygenation / ventilation<br> No<br> Screening at the peripheral level for the need of oxygen therapy and categorizing the patients with low cost point of care devices by frontline workers <br> Physiotherapy and mobilization
Aerosloized interventions - surfactant, furosemide<br> No<br> NIV and target oxygenation thresholds are the ones that need standardization. <br> Biological mechanisms of respiratory failure<br> NMBA <br> Nutritional support
Hyperglycemia management in critically ill patients
Hyperlipidemia management in critically ill patients <br> Boussignac CPAP (Vygon) is a low cost easy to use facemask CPAP-like system that connects to an oxygen flowmeter and generates flow dependent pressure (15 LPM generates 5cm H2O). It is used mostly for cardiogenic pulmonary oedema. It is unclear if this device would be beneficial in non-cardiogenic hypoxaemic respiratory failure.<br> None
<br> Bain Circuit CPAP<br> Triaging patients <br> Monitoring patients on mechanical ventilation <br> what is important is to investigate escalation strategies and AI guide strategies<br> IMPLEMENTATION OF SAFE RESPIRATORY SUPPORT AND DEVELOPING HUMAN RESOURCE CAPACITATION<br> Strategic oxygen access to LMICs<br> 1. Home based long term oxygen therapy services
2. Pulmonary rehabilitation services
3. Strengthening primary health centres to provide primary care for Asthma and COPD. Currently these services are only available at secondary and tertiary levels
4. Community education on chronic lung diseases, on prevention, health seeking behaviour, and community/home management
<br> Mobile oxygen systems including solar powered technology
AI and Oxygen delivery <br> CRRT in septic shock and multi organ failures.
Plasmapheresis in GBS or Myasthenia crisis.<br> Real-time monitoring methods including hemodynamic status<br> Personalization of respiratory support strategies<br> Head up position
Diuretic
Inhalation therapy
ET CO2<br> Blood components transfusion indications and outcomes<br> Optimal nebuliser therapy for mechanically ventilated patients<br> performance of oxygen saturation probes in patients with different skin colour<br> NONE<br> Psychosocial support <br> Hyperbaric oxygen Chambers <br> Economic policies that enable retention of skilled labor (technicians, nurses and doctors) trained to use these devices, in LMICs.<br> Escalation targets, for example ROX index as a cut off for the need for MV.
CPAP vs HFNC for cardiogenic pulmonary edema
HFNC for hypoxemic TBI patients
Ketamine vs Morphine  for sedalgesia <br> no<br> Early mobilitation<br> Use of diuretics in massive pulmonary oedema/fluid overload
Nebulizer therapy in severe asthmatic attacks
Use of cortico-steroids in Pneumonia complicated with septic shock.
etc.
<br> Early mobilisation and physiotherapy<br> Oxygen provision and utilisation
Effective physiotherapeutic and source control strategies for LRTI
Safe use of chest drains
Microbiological sampling to optimise diagnosis and antimicrobial stewardship
Prehab and rehab strategies for individuals with chronic respiratory disease
Treatment escalation planning for patients who are nearing end of life.<br> End of life decision making discussions with patients with chronic lung diseases before patients deteriorate requiring oxygen support and family involvement strategies.</p>
<p>Pulmonary rehabilitation/physiotherapist involvement strategy  in patients on oxygen support<br> Adjunctive mobility/ rehabiltation for patients receiving supplemental oxygen<br> Chest physiotherapy<br> It is very clear the APRV when applied correctly has many benefits to improve patient outcome.  Not only does it increase gas exchange efficiency (both oxygenation and ventilation) improving V/Q matching, Crs, and lung aeration homogeneity while using a lower mechanical power, it improves systemic hemodynamics reducing vasopressor requirements and is more comfortable allowing patients to be awake and mobilized.  This MV strategy should be popularized as it has the potential to reduce mortality and need for ECMO, while also shortening LOS in ICU and on MV.<br> I think the timing of all of the intervention/support listed in the previous question is very important.  <br> Patient and family engagement in providing Quality of Life goals concordant care in ICU<br> family support<br> Not at this point<br> Whether rehabilitation works to improve oxygeneation<br> Participation in toilet/hygiene as prevention of and recovery from respiratory decompensation<br> Neuromuscular blocker support<br> Antimicrobials, Nutrition support<br> Use of Albuterol<br> Training of support personnel<br> NEBULIZATION
PULMONARY THERAPY
HOME VENTILATION</p>
<p><br> Respiratory system have its own impact on the whole body ,so comorbidities should be managed timely ( interorgan cross talk )<br> No<br> No<br> Saturation checks constantly <br> Respiratory mechanics assessment and synchrony with invasive mechanical ventilation.  When to liberalize targets when weaning invasive support.<br> Checking oxygen saturation <br> Provision of high function oxygen support equipment with a quick follow up training on how to use them<br> Nutritional  support  is very important <br> Aseptic measures<br> Spontanious breathing trial and sedation awakining teial<br> Pediatric applications of all of this cannot be ignored<br> Home support to those who are on NIV<br> None for now<br> Oesophageal manometry and transpulmonary pressure measurement, EIT</p>
</div></div></td></tr>
  </tbody>
  
  
</table>
</div>
</body>
</html>
